This series of collaborations demonstrates Ultivue's goal of accelerating biomarker discovery and validation in tissue samples. Aspects of the collaborations include the availability of flexible image analysis solutions by Visiopharm and Indica Labs, tailored to each unique mIF assay. Additionally, collaborative agreements with Aignostics, Keen Eye, and Nucleai will allow Ultivue to provide AI technology that complements this mIF assay analysis in larger cohorts. This results in improved hands-on time per image and greater consistency of image readouts. Through Ultivue's collaboration with Paige and Zegami, the company will also be able to implement AI analytics into clinical workflows, paired with interactive image exploration and data analysis for improved quality control.